John Smith is considered one of the country’s premiere experts on non-invasive glucose monitoring technology. He previously served as Vice President and Chief Scientific Officer of Johnson & Johnson’s LifeScan, a world market leader in blood glucose monitoring systems. John now consults for companies pursuing noninvasive glucose methods, and for investors who fund them. He is the author of The Pursuit of Noninvasive Glucose: “Hunting the Deceitful Turkey,” which is available for download here. He’s…Read more »
I hereby interrupt my vacation to bring you some exciting diabetes technology news. Some of you may know that the American Association of Diabetes Educators (AADE) is holding its annual conference in Atlanta on Aug. 5-8. This event takes a close second to the ADA’s big annual shindig in June as the biggest event of the year for launching new diabetes products and programs.
Some cool stuff being officially unveiled next week:
* A new…Read more »
Welcome to Round 2 of my new blast-from-the-past series here at DiabetesMine. Once again, I note how little things have changed in four years! This post originally appeared exactly four years ago to the day, but if I didn’t tell you that, you might not notice. That’s because using the standard deviation for evaluating glucose results remains a much-discussed but not universally accepted method. Enjoy…
Standard Deviation Buzz
There seems to be a lot…
Since I got Type 1 diabetes at the ripe old age of 30+, I never had the experience of “leaving the nest” with the Big D. So I recently asked fellow blogger and advocate Allison Blass what that was like: Did your parents fall apart? Were you scared to death, or more elated? What she came back with was actually more of a practical nature: the top tips she wished she’d known at the time.…Read more »
Slowly but surely, a fully integrated “closed loop” or “artificial pancreas” system doesn’t seem so pie-in-the-sky anymore.
By that I mean: the real diabetes device news coming out of this week’s annual ADA Conference was not any product launch in particular, but what I view as a “clear and present” push towards a more automated diabetes management system.
For starters, see the new pre-conference special edition of Diabetes Technology & Therapeutics, all about “accelerating the…